Latest Commercialisation News

Chilwa Minerals confirms robust metallurgical testwork results from its Mposa deposit, revealing multiple valuable mineral product streams including high-quality ilmenite and zircon. The findings underpin a promising pathway toward diversified revenue and strategic rare earth by-products.

HITIQ Ltd has raised $250,000 through a premium-priced placement and secured a $1.4 million RDTI loan facility to support its pivot towards consumer concussion management technology.

NOVONIX has delivered its first commercial-grade synthetic graphite sample at mass production scale, marking a key step toward expanding its battery and industrial materials footprint.

EMVision Medical Devices launches a $2 million Share Purchase Plan offering shares at a 16.4% discount, bundled with free options exercisable at $3.40, aiming to bolster clinical and commercial milestones.

FirstWave Cloud Technology is securing $2.5 million to accelerate growth through AI-driven compliance tools and the rollout of its NMIS Cloud service with Telmex, leveraging a vast existing user base and new global partnerships.

INOVIQ Limited has obtained exclusive worldwide rights to novel ovarian cancer biomarker IP from UniQuest, propelling its EXO-OC™ test closer to commercial launch. The test’s exceptional sensitivity and specificity position it as a potential breakthrough in early cancer detection.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

1414 Degrees has returned to trading after issuing 35.7 million shares to US investor Lind Global Fund II, with approval for an additional 14.3 million shares pending at the upcoming AGM.

Environmental Clean Technologies Limited (ECT) is set to acquire exclusive rights to Rice University’s innovative Flash Joule Heating technology, promising a breakthrough in PFAS soil remediation. The company also announces a $3 million capital raise to accelerate development and commercialisation.

Latrobe Magnesium Limited has successfully commenced production of Magnesium Oxide at its Hazelwood North Demonstration Plant, marking a significant operational milestone. The company is advancing towards steady-state output and exploring by-product commercialisation.

Strategic Elements Ltd has successfully fabricated over 2,000 Energy Ink™ prototype cells in a commercial setting, marking a pivotal step toward global collaboration and product development. This breakthrough validates the reproducibility of their moisture-powered printable ink technology at scale.

Green Critical Minerals has locked in a $5.2 million underwriting agreement to support the exercise of its expiring options, reinforcing its commercialisation strategy for innovative VHD graphite technology.